SCHEMBL8307910

SCHEMBL8307910

Cc1nc(-c2ccccc2)n(C)c1C=NO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.47
ALOX15 P16050 1/20 0.41
HTT P42858 1/20 0.41
DHODH Q02127 1/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 1/20 0.40
TLR7 Q9NYK1 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ATM Q13315 1/20 0.39
ADORA2A P29274 2/20 0.38
ADORA2B P29275 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
PTGER1 P34995 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ADORA3 P0DMS8 2/20 0.37
ADORA1 P30542 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8307908 1.00 KDM4E (0.47) KDM4EALOX15HTTDHODHALDH1A1
SCHEMBL8310056 0.78 TARBP2 (0.34) KDM4EDHODHALDH1A1CYP1A2SMN1; SMN2
SCHEMBL8310061 0.78 TARBP2 (0.34) KDM4EDHODHALDH1A1CYP1A2SMN1; SMN2
SCHEMBL11515633 0.73 PTGER1 (0.47) KDM4EALOX15HTTDHODHALDH1A1
SCHEMBL719704 0.72 CYP1A2 (0.46) KDM4EHTTDHODHALDH1A1CYP1A2
SCHEMBL5795858 0.71 ATM (0.47) KDM4EALOX15DHODHALDH1A1CYP1A2
SCHEMBL14679564 0.71 ADORA2A (0.40) KDM4EALDH1A1ATMADORA2AADORA2B
SCHEMBL27690602 0.70 ATM (0.46) KDM4EALOX15DHODHALDH1A1CYP1A2
SCHEMBL11312831 0.68 CYP1A2 (0.58) DHODHALDH1A1CYP1A2SMN1; SMN2ATM
SCHEMBL8313263 0.68 KMT2A (0.50) KDM4EALOX15ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed